Smith Beth Ann bought MGNX
February 15, 2026 · Form 4 insider transaction
Smith Beth Ann bought 1,095 shares of MacroGenics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,095
Price
N/A
Total value
N/A
InsiderSmith Beth Ann
Role—
CompanyMacroGenics, Inc. (MGNX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 15, 2026
Filing dateFebruary 17, 2026
Shares owned after13,204
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.